Announcements Trials
Browse Landscape

Phase

Phase 3 17Phase 4 14Phase NA 8Phase 2 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 1

Status

Withdrawn 2Recruiting 2Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Endocrine 1Breast 1

Conditions

Thrombocytopenia 2Hemorrhage 2Postoperative Hemorrhage 1Pituitary Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Tranexamic Acid × Clear all
NCT06599762 2026-04-22

MYELO-CAN:TXA

University of Manitoba

Phase 2 Recruiting
75 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Vanderbilt University Medical Center

Phase 2 Recruiting
100 enrolled

Postoperative Hemorrhage

NCT05554211 2025-02-21

Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

Northwestern University

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT03801122 2023-05-06

TTRAP-Bleeding

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed
18 enrolled
Classical hematologyOther hematologic neoplasm

Hemorrhage, Thrombocytopenia, Hematologic Neoplasms

NCT04863339 2022-04-05

Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

University of North Carolina, Chapel Hill

Phase 2 Withdrawn
Endocrine

Hemorrhage, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡